RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY (CHT) WITH HIGH-DOSE METHOTREXATE (MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (ARAC) FOR PATIENTS (PTS) WITH PRIMARY CNS LYMPHOMA (PCNSL): THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG) #20 TRIAL

Ferreri JM;Foppoli M;Martelli M;Pangalis G;Frezzato M;Cabras G;Fabbri A;Corazzelli G;Ilariucci F;Rossi G;Soffietti R;Stelitano C;Vallisa D;Zaja F;Zoppegno L;Aondio G;Avvisati G;Balzarotti M;Brandes AA;Fajardo J;Gomez H;Guarini A;Pinotti G;Rigacci L;Uhlmann C;PONZONI , MAURILIO;Reni M;Zucca E;Cavalli F.

2008-01-01